Johnson Controls International plc
NYSE:JCIIndustrial - Machinery
+$1.42 today
- Market cap
- $83.08B
- Beta
- 1.34
- P/E (TTM)
- 24.9
- EPS (TTM)
- $5.82
- Dividend yield
- 1.10%
Volume 4.59M
Average 3.58M
JCI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Johnson Controls International plcNYSE: JCI
Research & Development · Q3 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $273M.
Context
- Research & development amounted to 1.2% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $68.25M.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 273M USD
- Year-over-year change
- +2.2%
- 4-year CAGR
- -0.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 273M | +2.2% |
| FY2024 | 2024-09-30 | 267M | +6.4% |
| FY2023 | 2023-09-30 | 251M | — |
| FY2022 | 2022-09-30 | 0 | -100.0% |
| FY2021 | 2021-09-30 | 275M | — |
Research & Development vs competitors
How JCI compares with its peers on the latest reported figures
- JCI's LTM Jun 2026 research & development of $273M is the 3rd highest of the 9 companies compared; the peer median is $0.
- Its year-over-year change of +2.2% is the highest of 3, against a peer median of -8.8%.
- Research & development amounts to 1.1% of revenue for JCI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.65B | -10.5% | +7.0% | 5.4% | |
| LTM Jun 2026 | $602M | -7.1% | +14.5% | 2.7% | |
| LTM Jun 2026 | $273M | +2.2% | — | 1.1% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding JCI) | $0 | -8.8% | +10.8% | 0.0% | |
Competitors are the stored peer set for JCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 23.67B | 20.64B | 22.33B | 22.95B | 23.6B |
| Cost of Revenue | 15.62B | 13.55B | 14.51B | 14.87B | 15B |
| Gross Profit | 8.05B | 7.09B | 7.82B | 8.08B | 8.59B |
| Gross Margin | 34.0% | 34.4% | 35.0% | 35.2% | 36.4% |
| Research & Development | 275M | 0 | 251M | 267M | 273M |
| Selling, General & Admin | 5.01B | 5.08B | 5.14B | 5.39B | 5.76B |
| Operating Expenses | 5.28B | 5.08B | 5.39B | 5.66B | 5.76B |
| Depreciation & Amortization | 845M | 717M | 745M | 816M | 865M |
| EBITDA | 3.88B | 2.05B | 2.1B | 2.8B | 3.15B |
| EBITDA Margin | 16.4% | 9.9% | 9.4% | 12.2% | 13.4% |
| Operating Income | 2.77B | 2.01B | 2.44B | 2.42B | 2.83B |
| Operating Margin | 11.7% | 9.7% | 10.9% | 10.5% | 12.0% |
| Interest Income | 9M | 6M | 17M | 17M | 19M |
| Interest Expense | 418M | 337M | 245M | 462M | 157M |
| Other Income / Expenses | (153M) | (900M) | (1.32B) | (899M) | (859M) |
| Income Before Tax | 2.61B | 1.11B | 1.11B | 1.52B | 1.97B |
| Pre-Tax Margin | 11.0% | 5.4% | 5.0% | 6.6% | 8.3% |
| Income Tax Expense | 868M | (182M) | (468M) | 111M | 245M |
| Net Income | 1.64B | 1.53B | 1.85B | 1.71B | 3.29B |
| Net Margin | 6.9% | 7.4% | 8.3% | 7.4% | 13.9% |
| EPS (Basic) | 2.31 | 2.22 | 2.70 | 2.53 | 2.64 |
| EPS (Diluted) | 2.27 | 2.19 | 2.69 | 2.52 | 2.63 |
| Weighted Avg Shares | 679M | 679M | 679M | 673.8M | 651.8M |
| Weighted Avg Shares (Diluted) | 721.1M | 679M | 679M | 676M | 654.1M |
Johnson Controls International plc
NYSE:JCI
Intrinsic Alpha fair value
Locked
Current Price
$138.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.